Skip to main content
logo
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
44.26
-0.45 (-1.01%)
At close: Dec 5, 2025, 4:00 PM EST
44.28
+0.02 (0.05%)
After-hours: Dec 5, 2025, 5:59 PM EST

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $396.00K in the quarter ending September 30, 2025, a decrease of -81.77%. This brings the company's revenue in the last twelve months to $3.08M, down -42.64% year-over-year. In the year 2024, Dianthus Therapeutics had annual revenue of $6.24M with 120.63% growth.

Revenue (ttm)
$3.08M
Revenue Growth
-42.64%
P/S Ratio
616.53
Revenue / Employee
$39,462
Employees
78
Market Cap
1.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.24M3.41M120.63%
Dec 31, 20232.83M-3.59M-55.96%
Dec 31, 20226.42M4.94M334.76%
Dec 31, 20211.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

DNTH News

More News